Low expression of Foxo3a is Associated with Poor Prognosis in Ovarian Cancer Patients
Authors:
- Yueming ZhaoYZYueming Zhao
- Yuchan WangYWYuchan Wang
- Mudan LuMLMudan Lu
- Chun ChengCCChun Cheng
- Xiaodong HuangXHXiaodong Huang
- Dongmei ZhangDZDongmei Zhang
- Jianxin LuJLJianxin Lu
- Song HeSHSong He
- Aiguo ShenASAiguo Shen
- 1 January 2009
- journal article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 27 (1) , 52-59
Abstract
To investigate whether Foxo3a expression is correlated with p27(kip1) protein levels as well as how it might be clinically relevant, we evaluated the expression of Foxo3a in several ovarian tumors. Immunohistochemical analysis was performed in 63 cases of ovarian tumors. Ten cases were evaluated by Western blot analysis. There was a correlation observed between Foxo3a over-expression and clinic pathological parameters (p = 0.032). Kaplan-Meier survival analysis showed that Foxo3a low expression was significantly associated with poor prognosis of patients. It may be a useful prognostic marker and target in ovarian cancer.Keywords
This publication has 36 references indexed in Scilit:
- Age as a prognostic factor in ovarian carcinoma: The gynecologic oncology group experienceCancer, 2010
- IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3aCell, 2004
- Role of cell‐cycle regulatory proteins in gynecological cancerJournal of Cellular Physiology, 2003
- Implication of Malignancy and Prognosis of p27kip1, Cyclin E, and Cdk2 Expression in Epithelial Ovarian TumorsGynecologic Oncology, 2001
- Prognostic Implications of p27 and Cyclin E Protein Contents in Malignant LymphomasLeukemia & Lymphoma, 2001
- Forkhead Transcription Factor FKHR-L1 Modulates Cytokine-Dependent Transcriptional Regulation of p27 KIP1Molecular and Cellular Biology, 2000
- Protein Expression of the Cell-Cycle Inhibitor p27Kip1 in Malignant MelanomaThe American Journal of Pathology, 1998
- Inhibitors of mammalian G1 cyclin-dependent kinases.Genes & Development, 1995
- Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signalsCell, 1994
- Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferationInternational Journal of Cancer, 1983